Publicaciones en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (15)

2019

  1. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy

    Annals of Hematology, Vol. 98, Núm. 8, pp. 1953-1959

2013

  1. Short communication: Atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C

    AIDS Research and Human Retroviruses, Vol. 29, Núm. 2, pp. 223-225

2012

  1. Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients

    AIDS, Vol. 26, Núm. 13, pp. 1721-1724

2009

  1. Natural history of compensated hepatitis c virusrelated cirrhosis in HIV-infected patients

    Clinical Infectious Diseases, Vol. 49, Núm. 8, pp. 1274-1282

2008

  1. Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients

    AIDS, Vol. 22, Núm. 8, pp. 923-930

  2. Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 4, pp. 793-796

  3. Liver toxicity of antiretroviral combinations including atazanavir/ ritonavir in patients co-infected with HIV and hepatitis viruses: Impact of pre-existing liver fibrosis

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 4, pp. 925-932

2007

  1. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 6, pp. 1347-1354

  2. Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients

    Antiviral Therapy, Vol. 12, Núm. 8, pp. 1225-1235

2006

  1. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C

    Antiviral Therapy, Vol. 11, Núm. 7, pp. 839-846

  2. Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C

    Journal of Antimicrobial Chemotherapy, Vol. 58, Núm. 1, pp. 140-146

  3. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes

    Gut, Vol. 55, Núm. 3, pp. 409-414

2002

  1. Usefulness of sputum culture for diagnosis of bacterial pneumonia in HIV-infected patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 21, Núm. 5, pp. 362-367

2000

  1. Haemophilus influenzae pneumonia in human immunodeficiency virus- infected patients

    Clinical Infectious Diseases, Vol. 30, Núm. 3, pp. 461-465

  2. Ventricular mass and diastolic function in patients infected by the human immunodeficiency virus

    Heart, Vol. 84, Núm. 6, pp. 620-624